DVA Stock Recent News
DVA LATEST HEADLINES
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito Chickering - Deutsche Bank A.J. Rice - UBS Ryan Langston - TD Cowen Operator Good evening.
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.
DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders.
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.
DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session.
DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day.
DENVER , April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time.
In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day.